LONDON, Nov. 19, 2008-On 18 November 2008, the US FDA responded to AstraZeneca’s Citizen Petition surrounding the company’s concern about the approval of any generic version of Pulmicort Respules (budesonide inhalation suspension). While the FDA…
FDA Approves Banzel (rufinamide) as Adjunctive Treatment for Severe Epilepsy Disorder
Published in November 17th, 2008
Comments Off
WOODCLIFF LAKE, N.J., November 14, 2008/PRNewswire/ –Eisai Corporation of North America announced today that the U.S. Food and Drug Administration (FDA) approved Banzel (rufinamide) for the adjunctive treatment of seizures associated with…
FDA Approves Low-dose Regimen of Premarin Vaginal Cream to Treat Moderate to Severe Postmenopausal Dyspareunia - Painful Sexual Intercourse
Published in November 13th, 2008
Comments Off
COLLEGEVILLE, Pa., Nov. 13 /PRNewswire-FirstCall/ — Premarin (conjugated estrogens) Vaginal Cream 0.5 g has been approved by the U.S. Food and Drug Administration (FDA) for a new indication and a new less frequent twice-weekly dosing regimen to…
FDA Approves Low-dose Regimen of Premarin Vaginal Cream to Treat Moderate to Severe Postmenopausal Dyspareunia - Painful Sexual Intercourse
Published in November 13th, 2008
Comments Off
COLLEGEVILLE, Pa., Nov. 13 /PRNewswire-FirstCall/ — Premarin (conjugated estrogens) Vaginal Cream 0.5 g has been approved by the U.S. Food and Drug Administration (FDA) for a new indication and a new less frequent twice-weekly dosing regimen to…
FDA Approves 30-Minute Onset of Action for Focalin XR
Published in November 12th, 2008
Comments Off
Data indicate Focalin XR provides rapid and significant improvements in attention, behavior and academic productivity at 30 minutes post-dose
EAST HANOVER, N.J., November 12, 2008 /PRNewswire/ — The US Food and Drug Administration (FDA) has…
FDA Approves 30-Minute Onset of Action for Focalin XR
Published in November 12th, 2008
Comments Off
Data indicate Focalin XR provides rapid and significant improvements in attention, behavior and academic productivity at 30 minutes post-dose
EAST HANOVER, N.J., November 12, 2008 /PRNewswire/ — The US Food and Drug Administration (FDA) has…
EKR Therapeutics Broadens Its Ready-to-Use Cardene I.V. Product Offerings with FDA Approval of Double Concentration Premixed I.V. Bags
Published in November 11th, 2008
Comments Off
BEDMINSTER, N.J.–(BUSINESS WIRE)–Nov 11, 2008 - EKR Therapeutics, Inc., a specialty pharmaceutical company focused on providing novel products for the acute-care hospital setting, today announced that it received approval from the U.S. Food and…
EKR Therapeutics Broadens Its Ready-to-Use Cardene I.V. Product Offerings with FDA Approval of Double Concentration Premixed I.V. Bags
Published in November 11th, 2008
Comments Off
BEDMINSTER, N.J.–(BUSINESS WIRE)–Nov 11, 2008 - EKR Therapeutics, Inc., a specialty pharmaceutical company focused on providing novel products for the acute-care hospital setting, today announced that it received approval from the U.S. Food and…
FDA Approves Ranexa for First Line Anti Anginal Use
Published in November 6th, 2008
Comments Off
PALO ALTO, Calif., Nov. 6 /PRNewswire-FirstCall/ — CV Therapeutics, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved a new, first line indication for Ranexa (ranolazine extended-release tablets) for the treatment…
FDA Approves Additional Indication for Norditropin for Small for Gestational Age (SGA) in Children
Published in November 4th, 2008
Comments Off
PRINCETON, N.J., November 04, 2008 /PRNewswire-FirstCall/ –Children born with a condition that can prevent them from growing to a normal height now have a new treatment option available with the approval of Norditropin (somatropin [rDNA origin]…
Translators
Categories
- Addictions
- Alcohol Abuse
- Complementary and Alternative Medicine
- Drug Approvals
- Drug Evaluation and Research
- Drug Shortages
- Drugs and Food Information
- Food and Nutrition Information
- Health Information
- Illegal Drugs
- Medical Devices
- Medical Devices and Radiological Health
- Pharmaceutical Industry News
- Pharmacist News
- Safety Information
- Uncategorized
Archives
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- December 2007
- November 2007
- October 2007
- September 2007
- August 2007
- July 2007
- June 2007
- May 2007
- April 2007
- March 2007
- February 2007
- January 2007
- December 2006
- November 2006
- October 2006
- September 2006
- August 2006
- July 2006
- June 2006
- May 2006
- April 2006
- March 2006
- February 2006
- January 2006
- December 1969
Pages
Blogroll
- Alcohol / Addiction / Illegal Drugs News From Medical News Today - Latest Alcohol / Addiction / Illegal Drugs News From Medical News Today.
- Alcohol and Alcoholism - current issue - Alcohol and Alcoholism - RSS feed of current issue
- CDRH Consumer News - Items added to the Center for Devices and Radiological Health’s Consumer website within the last month.
- Centre for Reviews and Dissemination (CRD) - CRD undertakes reviews of research about the effects of interventions used in health and social care.
- Complementary and Alternative Medicine Specialist Library - This feed highlights some of the latest resources added to the Complementary and Alternative Medicine Specialist Library.
- Drugs.com - New Drug Applications - Reports of new drug applications (or withdrawals of such applications) by pharmaceutical companies.
- Drugs.com - New Drug Approvals - Reports of FDA and international regulatory bodies’ approvals of drugs currently in development.
- Drugs.com - Pharma News - Newsworthy items on a variety of topics related to the pharmaceutical industry and to the development, efficacy and safety of prescription and non-prescription drugs and supplements.
- Evidence-based Complementary and Alternative Medicine - current issue - Evidence-based Complementary and Alternative Medicine - RSS feed of current issue
- FDA Center for Drug Evaluation and Research - What’s New - What’s New at CDER